Bakjaji Shadi, Anglin Kathryn, Clotts Trish, Dorsten Bethany, Jones Kaitlyn, Young Cindy, Zoofan Samira, Abdel-Hadi Malak, Damilano Cecilia, Obrynba Kathryn
Division of Endocrinology, Department of Pediatrics, Nationwide Children's Hospital, Columbus, Ohio.
The Ohio State University College of Medicine, Columbus, Ohio.
Pediatr Qual Saf. 2025 Sep 11;10(5):e844. doi: 10.1097/pq9.0000000000000844. eCollection 2025 Sep-Oct.
Congenital hypothyroidism (CH) is a common endocrine disorder that requires optimal management and intensive follow-up to prevent neurocognitive impairment, especially within the first 3 years of life.
We implemented a quality improvement (QI) initiative to standardize care and reduce loss to follow-up for children younger than 3 years with CH. The project was conducted in a pediatric endocrinology clinic at a large tertiary hospital in the Midwestern United States from January 2021 to December 2024. The primary aim was to increase the percentage of patients younger than 3 years with CH who achieved 2 or more normal thyroid-stimulating hormone (TSH) levels within a rolling 12-month period, from a baseline of 77% to a goal of greater than 95%. A multidisciplinary QI team-endocrinologists, nurses, social workers, administrative staff, a certified QI specialist, and care coordinators-used Plan-Do-Study-Act cycles to optimize care. Data were collected monthly from the electronic medical record to identify patients who did not meet TSH targets or missed clinic visits. Key interventions included case management, standardized caregiver education, and identification of high-risk patients. The monthly cohort consisted of 74-124 children younger than 3 years with CH.
After 12 months of intervention, this initiative increased the percentage of unique patients younger than 3 years with CH who achieved 2 normal TSH values within a rolling 12-month period, from a baseline of 77%-94%-an improvement that has been sustained.
This QI initiative highlights the importance of interdisciplinary collaboration in improving the clinical care of pediatric patients with CH.
先天性甲状腺功能减退症(CH)是一种常见的内分泌疾病,需要进行优化管理和密切随访,以预防神经认知障碍,尤其是在生命的前3年内。
我们实施了一项质量改进(QI)计划,以规范对3岁以下CH患儿的护理,并减少失访情况。该项目于2021年1月至2024年12月在美国中西部一家大型三级医院的儿科内分泌诊所进行。主要目标是将3岁以下CH患儿在连续12个月内达到2次或更多次正常促甲状腺激素(TSH)水平的患者比例从基线的77%提高到超过95%的目标。一个多学科QI团队——内分泌学家、护士、社会工作者、行政人员、一名认证QI专家和护理协调员——使用计划-执行-研究-行动循环来优化护理。每月从电子病历中收集数据,以识别未达到TSH目标或错过门诊就诊的患者。关键干预措施包括病例管理、标准化的护理人员教育以及识别高危患者。每月的队列包括74-124名3岁以下的CH患儿。
经过12个月的干预,该计划将3岁以下CH患儿在连续12个月内达到2次正常TSH值的独特患者比例从基线的77%提高到了94%,且这一改善得以持续。
这项QI计划凸显了跨学科合作在改善CH儿科患者临床护理方面的重要性。